Hypertension (HT) and diabetes mellitus (DM) lead to structural and functional cardiac impairment and worsen the prognosis after myocardial infarction (MI). However, the prognosis of male or female patients with the coexistence of HT and DM after MI has not been clearly demonstrated. The study sample comprised 4317 consecutive patients with an acute MI from a prospective nationwide survey conducted in 1992, 1994 and 1996 in all 25 coronary care units operating in Israel. The in-hospital, 30-day and 1-year outcome of diabetic hypertensive patients (n ¼ 546) was compared with that of diabetic normotensive patients (n ¼ 547) and with that of nondiabetic hypertensive patients (n ¼ 1192) and nondiabetic normotensive subjects (n ¼ 2032). The crude in-hospital, 30-day and 1-year mortality rates of diabetic hypertensive patients (11.7, 16.5 and 27.6%, respectively) were significantly higher than those of the diabetic normotensive patients (9.5, 15.4 and 22.9%, respectively) and nondiabetic hypertensive patients (7.1, 11.6 and 17.6%, respectively). Kaplan-Meier survival curves showed increased mortality rates during the 1-year follow-up in diabetic hypertensive patients. Adjusted risk for 1-year mortality was increased in diabetic patients. However, the risk was similar in diabetic hypertensive and normotensive patients (hazard ratio (HR) 1.55, 95% confidence interval (CI) 1.25-1.93, and 1.62, 95% CI 1.29-2.04, respectively). Adjusted KaplanMeier survival curves of diabetic hypertensive patients converged with those of the diabetic normotensives. The existence of DM increases the 1-year mortality after MI by about 60%. However, controlled hypertension did not worsen the outcome of diabetic male or female patients after MI.
Introduction
Diabetes mellitus (DM) and hypertension (HT) are among the most common diseases in the modern world. 1, 2 The prevalence of HT is approximately twice as high in diabetic patients as in the nondiabetic population [3] [4] [5] and the frequency of both disorders increases with age. 1, 2, 6 These two disorders lead to structural and functional cardiac impairment and finally contribute to cardiovascular illness and mortality. 7, 8 Previous studies in the prethrombolytic and thrombolytic eras concur that diabetes is an independent risk for mortality postmyocardial-infarction (MI). [8] [9] [10] The worse post-MI outcome of diabetic patients was more pronounced in women. [11] [12] [13] Several studies have shown that HT is also associated with a worse prognosis post-MI. [14] [15] [16] However, the effect of the coexistence of HT and DM on the prognosis post-MI has not been clearly demonstrated.
The aim of this study was to assess, in a large group of diabetic men and women, the effect of a history of HT on the prognosis after MI.
Methods
Nationwide surveys, including all patients admitted with acute MI, were conducted during a 2-month period in 1992 and 1994 (January and February) in all 25 coronary care units operating in Israel. During 1996, the survey was extended to 5 months (January, February, May, June and July). Demographic, clinical data and medical history were collected on special forms for 4317 consecutive patients with acute MI. The studied population included immigrants coming to Israel from various countries. Inhospital course, 30-day and 1-year mortality was assessed from the medical charts and by matching the identification number of patients with the Israeli National Population Registry. Only patients who survived the onset of MI and reached the ICCU where included in the surveys. The 30-day mortality data were missing for nine patients (0.2%), and 1-year mortality data were missing for 161 patients (3.7%).
Definitions
The diagnosis of acute MI was based on the presence of two of the following criteria: pain suggestive of MI lasting for at least 30 min; unequivocal new electrocardiographic alterations; or increase of creatinine kinase (CK) and MB isoenzyme to more than 1.5 the upper limit. We included in the study patients with ST elevation or non-ST elevation MI.
Stroke was defined as a new irreversible neurological event.
Hyperlipidaemia was defined when the patient was treated for hyperlipidaemia or when previously diagnosed as having hyperlipidaemia by the primary physician. The diagnosis of DM and HT was made on the basis of the reported history and medical records. DM was defined by chronic use of antihyperglycaemic drugs or previous documentation of fasting glucose levels 4140 mg/dl (7.77 mmol/l). HT was defined by chronic use of antihypertensive drugs or a previously documented blood pressure X160/95 mmHg.
Statistical analysis
Data are presented as mean 7 SD. SAS statistical software was used for analysis. 17 Comparisons between groups were made using w 2 tests for discrete variables and one-way ANOVA for continuous variables. To estimate 7-and 30-day mortality in terms of odds ratio (OR) with 95% confidence interval (CI), a stepwise logistic regression analysis (SAS Logistic Procedure) was performed, adjusting for age, sex, past MI, history of angina, Killip class, anterior location of MI, thrombolytic therapy and angioplasty or bypass surgery during hospitalization. As a reference we used the group of nondiabetic normotensive patients. A stepwise Cox proportional hazards regression model (SAS PHREG Procedure) adjusting for the same variables was used to compare cumulative 1-year mortality in terms of hazard ratio (HR) and 95% CI. As a reference we used the group of nondiabetic normotensive patients. A variable was allowed to enter into the model if it made a significant contribution at the 0.15 level of significance and was removed if after subsequent addition of other variables to the model, it no longer made a contribution at the 0.10 level of significance. Kaplan-Meier survival curves were produced using the SAS Lifetest Procedure. Adjusted survival curves were computed using variables entered into the best-selected Cox model (SAS PHREG Procedure).
Results

Patient characteristics and admission parameters
A total of 4317 MI patients were included in the study. A total of 1093 patients had DM of whom 11.4% were treated with insulin. Of these, 546 patients also had a history of HT and 547 were normotensive. In all, 3224 patients were nondiabetic, among whom 1192 patients were hypertensive and 2032 patients were normotensive. Patient characteristics and parameters on admission to the coronary care units are given in Table 1 . Patients having DM and HT were older, more frequently women and more likely to have a previous history of MI, angina and stroke. Risk factors such as smoking and family history were relatively less frequent in those with coexistence of HT and DM. On admission to the coronary care unit, patients with the coexistence of HT and DM had a higher heart rate and Killip grade than the other groups (Table 1) .
In-hospital complications and management
Congestive heart failure and shock were significantly more frequent in those with HT and DM ( Table 2 ). Hypertensive patients with and without DM received less thrombolytic therapy and were less likely to undergo coronary catheterization during hospitalization (Table 3) . Diabetic patients with HT had relatively more revascularization by bypass surgery than with angioplasty. They were also treated more frequently with angiotensin converting enzyme (ACE) inhibitors, nitrates and calcium channel blockers and less frequently with beta-blockers (Table 3) .
Mortality
The crude in-hospital, 30-day, 1-year and 30-day to 1-year mortality rates of the diabetic hypertensive patients were significantly higher in comparison with the other groups (Table 4) . After adjustments were made for age, sex, past MI, history of angina, Killip class, anterior location of MI, thrombolytic therapy and angioplasty or bypass surgery, the risk of death in diabetic patients remained significantly higher (Table 5 ). However, the risk was similar in those with or without a history of HT (Table 5) . Interactions of DM and HT were nonsignificant (P ¼ 0.74, 0.23, 0.28 and 0.92 for in-hospital, 30-day, 1-year and 30-day to 1-year mortality, respectively). Kaplan-Meier survival curves (Figure 1a ) show increased mortality rates during the 1-year follow-up in diabetic hypertensive patients. However, after adjustment for the above variables, the curves of diabetic patients with and those without a history of HT converged (Figure 1b) .
Influence of DM and HT by gender
Of the 4317 MI patients, 1117 (25.9%) were females. Female patients were older than males (mean 69 7 11 vs 61 7 12 years) and were more likely to be hypertensive (56.3 vs 34.6%) and diabetic (34.1 vs 22.3%). The coexistence of HT and DM was present in 233 (20.9%) female and 313 (9.8%) male patients. The crude in-hospital, 30-day, 1-year and 30-day to 1-year mortality rates of diabetic hypertensives were significantly higher in both male and female patients. After adjustments were made for ACE=angiotensin converting enzyme.
Outcome after myocardial infarction in diabetic hypertensive patients M Jonas et al age, past MI, history of angina, Killip class, anterior location of MI, thrombolytic therapy and angioplasty or bypass surgery, the risk of death in diabetic patients with or without a history of HT was similar for both male and female patients. Nondiabetic, male or female patients, both with or without a history of HT, had a similar prognosis.
Discussion
In the present nationwide survey we failed to observe, in diabetic patients, an added risk of a history of HT on short and 1-year mortality of patients with acute MI. Although mortality rates were significantly higher in diabetic patients suffering from HT, adjustment for baseline characteristics, in male or female patients, did not show any interaction between HT and DM. As in previous studies, [3] [4] [5] we found that the coexistence of HT and DM was common (12.6%) among patients with MI. History of HT was recorded in 37% of the nondiabetic patients and its prevalence increased in diabetics to 44% in male and 61% in female patients. Since the definition of HT in diabetic patients has been changed, 18 the number of diabetic patients with HT would increase considerably. Thus, the 12.6% prevalence of coexisting HT and DM in the present survey is an underestimation of the association between HT and DM among patients with acute MI.
Considerable experimental and clinical evidence indicates that elevated blood pressure is critically important in the pathogenesis of diabetic heart disease. 2, 7 Coronary artery disease is much more common in patients with both DM and HT than in patients with DM or HT alone, and the development of atherosclerosis was found to be accelerated, with more plaque fissuring and a lower coronary perfusion reserve index, when DM and HT coexist. 2, 7, 19, 20 Patients with combined DM and HT also tend to Outcome after myocardial infarction in diabetic hypertensive patients M Jonas et al have impaired systolic and diastolic ventricular function with more left ventricular hypertrophy and congestive heart failure than counterparts with DM or HT alone. 7, 21, 22 As expected, we found that in diabetic hypertensive patients the in-hospital and 1-year outcome was significantly worse compared to patients with DM or HT alone. However, after adjustments were made for different clinical variables, the risk of diabetic patients with or without a history of HT was similar. Elevated blood pressure accelerates diabetic heart disease. It is possible that 1-year of follow-up is not enough to see the effect of a history of HT on mortality post-MI. Alternatively, a history of HT may not increase mortality if blood pressure is well controlled. In the present study, the hypertensive patients received more treatment than the normotensive patients and their blood pressure was well controlled. Patients with coexisting DM and HT were more likely to be treated with ACE inhibitors, nitrates and calcium antagonists than those with DM alone. The average blood pressure on admission was 142.1/83.7 mmHg in the diabetic hypertensive patients and 139.7/82.2 mmHg in the nondiabetic hypertensive patients suggesting a good control of blood pressure. It is also possible that in some hypertensive patients blood pressure dropped after MI and therefore hypertension was even better controlled. If this is the case, strict blood pressure control can eliminate the added risk of HT to DM and thereby improve prognosis of diabetic patients with ischaemic heart disease. 23 , 24 Tenenbaum et al 25 recently showed that HT is an independent predictor of increased mortality in diet-treated but not in pharmacologically treated diabetic patients with chronic ischaemic heart disease, suggesting the possible benefit of early blood pressure control in this population. The protection conferred on the diabetic patients treated intensively for HT was also evident in the Hypertension Optimal Treatment (HOT) study. 26 In this study, diabetic hypertensive patients benefited the most from intensive blood pressure lowering, with a 51% reduction in major cardiovascular events in the target group of diastolic blood pressure p80 mmHg compared with the p90 mmHg group. 26 Different studies noted a gender difference in the impact of diabetes on the outcome post-MI, with females having a worse prognosis. [11] [12] [13] In the present analysis of patients with MI, the combination of DM and HT was more common in females, but after multiple adjustments the risk of death was similar among male and female patients with combined DM and HT.
Limitations
Information on blood pressure and diabetes control over the follow-up period is lacking and therefore we cannot assess directly its impact on prognosis. The present study includes data on in-hospital complications and 1-year mortality but no information on nonfatal cardiovascular events is available. We cannot exclude an independent significant morbidity effect of combined diabetes and HT after MI.
Conclusions
The prevalence of coexisting HT and DM was high in unselected, consecutive patients with an acute MI. Diabetic patients exhibit a remarkable higher 1-year mortality post-MI than nondiabetic patients.
We did not find the expected independent added risk of a history of HT in diabetic male or female patients.
